Human memory-like NK cells migrating to tuberculous pleural fluid via IP-10/CXCR3 and SDF-1/CXCR4 axis produce IFN-γ in response to Bacille Calmette Guerin-Reference-Cited by-同舟云学术

Human memory-like NK cells migrating to tuberculous pleural fluid via IP-10/CXCR3 and SDF-1/CXCR4 axis produce IFN-γ in response to Bacille Calmette Guerin

Published:2013-07 Issue:1 Volume:148 Page:113-123
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Fu Xiaoying,Yang Binyan,Lao Suihua,Fan Yanying,Wu Changyou

Funder

National Nature Science Foundation of China

Doctoral Program of Higher Education of China

Academic New Talent Award of Ministry of Education from China

Sun Yat-sen University

Specialized Research Fund for the Doctor Program of Higher Education of China

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting;Manabe;Nat. Med.,2000

2. Tuberculosis: back on the immunologists' agenda;Kaufmann;Immunity,2006

3. Tuberculosis control: challenges of an ancient and ongoing epidemic;Cummings;Public Health Rep.,2007

4. Tuberculosis: a new look at an old disease;Rezaei;Expert Rev. Clin. Immunol.,2011

5. Tuberculosis subunit vaccine design: the conflict of antigenicity and immunogenicity;Sable;Clin. Immunol.,2007

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and function of a novel human memory-like NK cell population expressing CD160 in melioidosis;iScience;2023-08

2. Immunologic Role of Innate Lymphoid Cells against Mycobacterial tuberculosis Infection;Biomedicines;2022-11-06

3. Natural killer cell‑based immunotherapy for lung cancer: Challenges and perspectives (Review);Oncology Reports;2021-09-08

4. Chemokine networks modulating natural killer cell trafficking to solid tumors;Cytokine & Growth Factor Reviews;2021-06

5. Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy;ACS Applied Materials & Interfaces;2020-12-08